Trial Profile
Phase II study of carboplatin plus nab-paclitaxel in advanced lung squamous cell carcinoma
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 21 Nov 2013
Price :
$35
*
At a glance
- Drugs Carboplatin (Primary) ; Paclitaxel (Primary)
- Indications Lung cancer
- Focus Therapeutic Use
- 21 Nov 2013 New trial record